| Year |
Citation |
Score |
| 2023 |
Morató X, Fernández-Dueñas V, Pérez-Villamor P, Valle-León M, Vela JM, Merlos M, Burgueño J, Ciruela F. Development of a Novel σ Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells. Acs Chemical Neuroscience. PMID 37191585 DOI: 10.1021/acschemneuro.3c00206 |
0.736 |
|
| 2021 |
Mattila SO, Tuhkanen HE, Lackman JJ, Konzack A, Morató X, Argerich J, Saftig P, Ciruela F, Petäjä-Repo UE. GPR37 is processed in the N-terminal ectodomain by ADAM10 and furin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21654. PMID 34042202 DOI: 10.1096/fj.202002385RR |
0.584 |
|
| 2021 |
Morató X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, Borràs E, Sabidó E, Petäjä-Repo UE, Fernández-Dueñas V, Ferrer I, Svenningsson P, Ciruela F. Ecto-GPR37: a potential biomarker for Parkinson's disease. Translational Neurodegeneration. 10: 8. PMID 33637132 DOI: 10.1186/s40035-021-00232-7 |
0.542 |
|
| 2020 |
Betari N, Sahlholm K, Morató X, Godoy-Marín H, Jáuregui O, Teigen K, Ciruela F, Haavik J. Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole- and Investigations. Frontiers in Pharmacology. 11: 593416. PMID 33324221 DOI: 10.3389/fphar.2020.593416 |
0.638 |
|
| 2019 |
Morato X, Cunha RA, Ciruela F. G protein-coupled receptor 37 (GPR37) emerges as an important modulator of adenosinergic transmission in the striatum. Neural Regeneration Research. 14: 1912-1914. PMID 31290447 DOI: 10.4103/1673-5374.259610 |
0.57 |
|
| 2018 |
Morató X, Gonçalves FQ, Lopes JP, Jauregui O, Soler C, Fernández-Dueñas V, Cunha RA, Ciruela F. Chronic adenosine A receptor blockade induces locomotor sensitization and potentiates striatal LTD in GPR37 deficient mice. Journal of Neurochemistry. PMID 30578680 DOI: 10.1111/Jnc.14653 |
0.528 |
|
| 2018 |
Gómez-Soler M, Cordobilla B, Morató X, Fernández-Dueñas V, Domingo JC, Ciruela F. Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism. Frontiers in Neuroscience. 12: 604. PMID 30233293 DOI: 10.3389/Fnins.2018.00604 |
0.696 |
|
| 2018 |
Morató X, Luján R, Gonçalves N, Watanabe M, Altafaj X, Carvalho AL, Fernández-Dueñas V, Cunha RA, Ciruela F. Metabotropic glutamate type 5 receptor requires contactin-associated protein 1 to control memory formation. Human Molecular Genetics. PMID 30010864 DOI: 10.1093/Hmg/Ddy264 |
0.538 |
|
| 2017 |
Morató X, Luján R, López-Cano M, Gandía J, Stagljar I, Watanabe M, Cunha RA, Fernández-Dueñas V, Ciruela F. The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo. Scientific Reports. 7: 9452. PMID 28842709 DOI: 10.1038/S41598-017-10147-X |
0.771 |
|
| 2017 |
Morató X, López-Cano M, Canas PM, Cunha RA, Ciruela F. Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization. Journal of Visualized Experiments : Jove. PMID 28570537 DOI: 10.3791/55661 |
0.472 |
|
| 2017 |
Oliveira PA, Dalton JAR, López-Cano M, Ricarte A, Morató X, Matheus FC, Cunha AS, Müller CE, Takahashi RN, Fernández-Dueñas V, Giraldo J, Prediger RD, Ciruela F. Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia. Scientific Reports. 7: 1857. PMID 28500295 DOI: 10.1038/S41598-017-02037-Z |
0.616 |
|
| 2017 |
Sokolina K, Kittanakom S, Snider J, Kotlyar M, Maurice P, Gandía J, Benleulmi-Chaachoua A, Tadagaki K, Oishi A, Wong V, Malty RH, Deineko V, Aoki H, Amin S, Yao Z, et al. Systematic protein-protein interaction mapping for clinically relevant human GPCRs. Molecular Systems Biology. 13: 918. PMID 28298427 DOI: 10.15252/Msb.20167430 |
0.725 |
|
| 2017 |
Fernández-Dueñas V, Azuaje J, Morató X, Cordobilla B, Domingo JC, Sotelo E, Ciruela F. Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid. Molecules (Basel, Switzerland). 22. PMID 28264466 DOI: 10.3390/Molecules22030366 |
0.566 |
|
| 2016 |
Rial D, Morató X, Real JI, Gonçalves FQ, Stagljar I, Pereira FC, Fernández-Dueñas V, Cunha RA, Ciruela F. Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses. Neuroscience Letters. PMID 28007645 DOI: 10.1016/J.Neulet.2016.12.040 |
0.472 |
|
| 2015 |
Gandía J, Morató X, Stagljar I, Fernández-Dueñas V, Ciruela F. Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent. Behavioural Brain Research. 288: 103-6. PMID 25862943 DOI: 10.1016/J.Bbr.2015.04.001 |
0.756 |
|
| 2015 |
Lopes JP, Morató X, Souza C, Pinhal C, Machado NJ, Canas PM, Silva HB, Stagljar I, Gandía J, Fernández-Dueñas V, Luján R, Cunha RA, Ciruela F. The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system. Journal of Neurochemistry. 134: 135-46. PMID 25824528 DOI: 10.1111/Jnc.13109 |
0.736 |
|
| 2013 |
Gandía J, Fernández-Dueñas V, Morató X, Caltabiano G, González-Muñiz R, Pardo L, Stagljar I, Ciruela F. The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain. Journal of Neurochemistry. 125: 362-72. PMID 23398388 DOI: 10.1111/Jnc.12196 |
0.754 |
|
| Show low-probability matches. |